Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson–Forssman–Lehmann (BFLS) and White–Kernohan (WHIKERS) Syndromes
Genes · 04.08.2025 · 16 (8) · 933
DOI: 10.3390/genes16080933 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, online erschienen am 04.08.2025. Verfasst von Keri Ramsey und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rare Childhood Disorders, Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA. Hauptthemen laut MEDLINE: Developmental Disabilities, Intellectual Disability, Epigenesis, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Translational Genomics Research Institute, TGen (Translational Genomics Research Institute, part, of City of Hope), the Royal Children’s Hospital Foundation.
Abstract (Originalsprache)
Background
More than 1500 genes are associated with developmental delay and intellectual disability, with variants in many of these genes contributing to a shared phenotype. The discovery of variants of uncertain significance (VUS) found in these genes during genetic testing can lead to ambiguity and further delay in diagnosis and medical management. Phenotyping, additional genetic testing, and functional studies can all add valuable information to help reclassify these variants. Here we demonstrate the clinical utility of epigenetic signatures in prioritizing variants of uncertain significance in genes associated with developmental delay (DD) and intellectual disability (ID).
Methods
Genome sequencing was performed in a male with developmental delay. He was found to have VUSs in both PHF6 and DDB1 genes, linked with Börjeson–Forssman–Lehmann syndrome (BFLS) and White–Kernohan syndrome (WHIKERS), respectively. These two disorders share a similar phenotype but have distinct inheritance patterns and molecular pathogenic mechanisms. DNA methylation profiling (DNAm) of whole blood was performed using the clinically validated EpiSign assay.
Results
The proband’s methylation profile demonstrated a strong correlation with the BFLS methylation signature, supporting the PHF6 variant as a likely cause of his neurodevelopmental disorder.
Conclusions
Epigenetic testing for disorders with distinct methylation patterns can provide diagnostic utility when a patient presents with variants of uncertain significance in genes associated with developmental delay. Epigenetic signatures can also guide genetic counselling and family planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Rare Childhood Disorders, Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, USA.
- Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
- Verspeeten Clinical Genome Center, London Health Sciences Center, London, ON N6A 5W9, Canada.
- Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 5C1, Canada.
- Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia.
- Department of Paediatrics, Univerwsity of Melbourne, Melbourne, VIC 3010, Australia.
ORCID-Profile: Jennifer Kerkhof, Newell Belnap, Wayne Jepsen, Matthew Huentelman, Saunder Bernes, Vinodh Narayanan, Shagun Kaur
Förderung
- Translational Genomics Research Institute
- TGen (Translational Genomics Research Institute, part, of City of Hope)
- the Royal Children’s Hospital Foundation
- the Murdoch Children’s Research Institute
- The Harbig Foundation
- Paula Fox
- The Andrew and Geraldine Buxton Foundation
- The Pierce Armstrong Foundation
Zitieren
APA
Ramsey, K., Prakash, S., Kerkhof, J., Sadikovic, B., White, S., Naymik, M., Sloan, J., Bonfitto, A., Belnap, N., Sanchez-Castillo, M., Jepsen, W., Huentelman, M., Bernes, S., Narayanan, V., & Kaur, S. (2025). Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson–Forssman–Lehmann (BFLS) and White–Kernohan (WHIKERS) Syndromes. Genes, 16(8), 933. https://doi.org/10.3390/genes16080933
Vancouver
Ramsey K, Prakash S, Kerkhof J, Sadikovic B, White S, Naymik M, et al. Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson–Forssman–Lehmann (BFLS) and White–Kernohan (WHIKERS) Syndromes. Genes. 2025;16(8):933. doi:10.3390/genes16080933
BibTeX
@article{Ramsey2025,
author = {Ramsey, Keri and Prakash, Supraja and Kerkhof, Jennifer and Sadikovic, Bekim and White, Susan and Naymik, Marcus and Sloan, Jennifer and Bonfitto, Anna and Belnap, Newell and Sanchez-Castillo, Meredith and Jepsen, Wayne and Huentelman, Matthew and Bernes, Saunder and Narayanan, Vinodh and Kaur, Shagun},
title = {Integration of Genome and Epigenetic Testing in the Diagnostic Evaluation of Developmental Delay: Differentiating Börjeson–Forssman–Lehmann (BFLS) and White–Kernohan (WHIKERS) Syndromes},
journal = {Genes},
year = {2025},
volume = {16},
number = {8},
pages = {933},
doi = {10.3390/genes16080933}
}
EUVIMED